Mario J. Gabelli, a director and control person of Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), acquired 3,000 common shares of the company on November 25, 2024. The shares were purchased at a price of $10.18 each, totaling $30,540. Following this transaction, Gabelli holds 312,226 shares indirectly through GGCP, Inc., and other holdings include 220,760 shares directly and 6,380 shares indirectly through GPJ Retirement Partners, LLC. Gabelli, who is the CEO and controlling shareholder of GGCP, has less than a full interest in these entities and disclaims ownership beyond his indirect pecuniary interest.
InvestingPro Insights
Mario J. Gabelli's recent acquisition of Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) shares aligns with the company's stable dividend history. According to InvestingPro data, GRX boasts a dividend yield of 5.85% and has maintained dividend payments for 13 consecutive years. This consistent payout may be attractive to income-focused investors like Gabelli.
Despite the director's confidence, InvestingPro Tips highlight some challenges for GRX. The stock generally trades with low price volatility, which could appeal to risk-averse investors. However, the company suffers from weak gross profit margins and its valuation implies a poor free cash flow yield. These factors might explain the stock's current price of $10.26, which is 91.55% of its 52-week high.
GRX's market performance has been mixed, with a 1-year price total return of 23.84%, but a more modest 3-month return of -4.93%. The company's market capitalization stands at $161.95 million, placing it in the small-cap category.
For investors seeking a more comprehensive analysis, InvestingPro offers additional tips and metrics beyond those mentioned here. The platform provides a deeper dive into GRX's financial health and market position, which could be valuable for those considering following Gabelli's lead or evaluating their current holdings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.